Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Michael Savoy"'
Autor:
Howard Baer, Vernon Barger, James S. Gainer, Peisi Huang, Michael Savoy, Hasan Serce, Xerxes Tata
Publikováno v:
Physics Letters B, Vol 774, Iss C, Pp 451-455 (2017)
Weak scale supersymmetry (SUSY) remains a compelling extension of the Standard Model because it stabilizes the quantum corrections to the Higgs and W,Z boson masses. In natural SUSY models these corrections are, by definition, never much larger than
Externí odkaz:
https://doaj.org/article/d97676c242f347e2881f9a55c170f1ce
Autor:
Howard Baer, Vernon Barger, James S. Gainer, Peisi Huang, Michael Savoy, Dibyashree Sengupta, Xerxes Tata
Publikováno v:
European Physical Journal C: Particles and Fields, Vol 77, Iss 7, Pp 1-16 (2017)
Abstract Radiatively-driven natural SUSY (RNS) models enjoy electroweak naturalness at the 10% level while respecting LHC sparticle and Higgs mass constraints. Gluino and top-squark masses can range up to several TeV (with other squarks even heavier)
Externí odkaz:
https://doaj.org/article/303a2103f54240218847dced8113cdcb
Publikováno v:
Journal of High Energy Physics, Vol 2017, Iss 6, Pp 1-34 (2017)
Abstract The methodology of the heterotic mini-landscape attempts to zero in on phenomenologically viable corners of the string landscape where the effective low energy theory is the Minimal Supersymmetric Standard Model with localized grand unificat
Externí odkaz:
https://doaj.org/article/72a1e6afa625451cb8b3844561addd77
Publikováno v:
Physics Letters B, Vol 758, Iss C, Pp 113-117 (2016)
In supersymmetric models where the superpotential μ term is generated with μ≪msoft (e.g. from radiative Peccei–Quinn symmetry breaking or compactified string models with sequestration and stabilized moduli), and where the string landscape 1. fa
Externí odkaz:
https://doaj.org/article/a2a9942ba8834646bdc5c4d06cb5c6d5
Building a better data culture can be the path to better results and greater equity in schools. But what do we mean by data?Your students are not just statistics. They aren't simply a set of numbers or faceless dots on a proficiency scale. They are v
Autor:
Kayleigh R. Marx, Caitlin R. Rausch, Alexandra R. Lovell, Nicholas J. Short, Shilpa Paul, Nitin Jain, Jenessa Lee, J. Michael Savoy, Farhad Ravandi, Elias Jabbour
Publikováno v:
Leukemialymphoma.
Ponatinib plus Hyper-CVAD yields a five-year overall survival of 73% in patients with Philadelphia-positive acute lymphoblastic leukemia. Ponatinib dose intensity is associated with increased incidence of adverse effects (AEs), including vascular eve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fce5d131c39538a0b2ce9aeac22da27
https://pubmed.ncbi.nlm.nih.gov/36222579
https://pubmed.ncbi.nlm.nih.gov/36222579
Autor:
Shilpa Paul, Hagop Kantarjian, Koji Sasaki, Kayleigh Marx, Nitin Jain, J. Michael Savoy, Adam DiPippo, Nadya Jammal, Guillermo Montalban Bravo, Tapan Kadia, Guillermo Garcia‐Manero, Nicholas J. Short, Farhad Ravandi, Elias Jabbour
Publikováno v:
American journal of hematology. 98(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35b5a3059f7e4aec340af497470c45e4
https://pubmed.ncbi.nlm.nih.gov/35633516
https://pubmed.ncbi.nlm.nih.gov/35633516
Autor:
Kayleigh Marx, Farhad Ravandi, Nadya Jammal, Dimitrios P. Kontoyiannis, Marina Konopleva, Koichi Takahashi, Naveen Pemmaraju, Serena M. Chew, Ghayas C. Issa, J. Michael Savoy, Koji Sasaki, Courtney D. DiNardo, Lianchun Xiao, Caitlin R. Rausch, Abhishek Maiti, Maro Ohanian, Gautam Borthakur, Jing Ning, Nicholas J. Short, Hagop M. Kantarjian, Tapan M. Kadia, Naval Daver, Yesid Alvarado, Adam J. DiPippo
Publikováno v:
Cancer
Background Venetoclax (VEN) combined with the hypomethylating agent (HMA) azacitidine improves survival in patients aged ≥75 years with newly diagnosed acute myeloid leukemia (AML). VEN and HMA treatment can result in prolonged and often profound n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b209fa14abfb696045d98c034ea7534
https://doi.org/10.1002/cncr.33508
https://doi.org/10.1002/cncr.33508
Publikováno v:
Physical Review D. 103
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ce9d4803e130b0c94bfde77973e87e6
https://doi.org/10.1103/physrevd.103.059902
https://doi.org/10.1103/physrevd.103.059902
Publikováno v:
Therapeutic Advances in Hematology
Therapy for adult acute lymphoblastic leukemia (ALL) with multiagent cytotoxic chemotherapy has not been as successful as that for pediatric patients. The advent of targeted monoclonal antibodies against common cell surface antigens (i.e. CD19, CD20,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbc82de325e8a670258d4e6c665d3677
http://europepmc.org/articles/PMC7992772
http://europepmc.org/articles/PMC7992772